Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Lycopus Virginicus
Generic Name
Lycopus Virginicus
Active Ingredient
Lycopus VirginicusCategory
alpha-Adrenergic Agonist [EPC]
Variants
10
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 6 [hp_C]/6[hp_C] | PELLET | ORAL | 0220-3189 |
| 30 [hp_C]/1 | PELLET | ORAL | 37662-1039 |
| 1 [hp_M]/1 | PELLET | ORAL | 37662-1043 |
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Lycopus Virginicus, you must consult a qualified healthcare professional.
| 6 [hp_C]/1 | PELLET | ORAL | 37662-1037 |
| 1 [hp_Q]/1 | PELLET | ORAL | 37662-1044 |
| 12 [hp_C]/1 | PELLET | ORAL | 37662-1038 |
| 500 [hp_C]/1 | PELLET | ORAL | 37662-1042 |
| 100 [hp_C]/1 | PELLET | ORAL | 37662-1040 |
| 200 [hp_C]/1 | PELLET | ORAL | 37662-1041 |
| 30 [hp_C]/30[hp_C] | PELLET | ORAL | 0220-3194 |
Detailed information about Lycopus Virginicus
Lycopus Virginicus, also known as Bugleweed, is a botanical extract classified pharmacologically as an alpha-adrenergic agonist, frequently utilized for its sympatholytic effects and impact on thyroid hormone regulation.
The dosage of Lycopus Virginicus must be highly individualized, especially given its impact on the endocrine system. For general thyroid support or the management of mild palpitations, healthcare providers may suggest the following:
For use as an allergenic extract, dosing is strictly managed by an allergist through a series of escalating subcutaneous injections (immunotherapy), starting with very low concentrations to avoid anaphylaxis.
Lycopus Virginicus is generally not recommended for use in children under the age of 18 unless specifically directed by a pediatric endocrinologist or specialist. The potential for this drug to interfere with the developing hypothalamic-pituitary-thyroid (HPT) axis poses significant risks to growth and metabolic development. If prescribed, doses are typically calculated based on body surface area or weight, but clinical data in this population remains sparse.
Because Lycopus Virginicus is primarily excreted through the kidneys, patients with a glomerular filtration rate (GFR) below 60 mL/min should use this medication with caution. A dose reduction of 25-50% may be necessary to prevent the accumulation of active metabolites and potential toxicity.
In patients with significant liver disease (Child-Pugh Class B or C), the metabolism of phenolic acids may be impaired. Close monitoring of liver enzymes is recommended, and the lowest effective dose should be utilized.
Geriatric patients often have increased sensitivity to adrenergic agonists. There is an increased risk of bradycardia or hypotension in this population. Healthcare providers typically start elderly patients on the lowest possible dose and titrate upward slowly while monitoring cardiovascular stability.
To ensure maximum efficacy and safety, patients should adhere to the following guidelines:
If a dose is missed, it should be taken as soon as the patient remembers. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Do not double the dose to catch up, as this increases the risk of acute thyroid suppression or cardiovascular side effects.
Signs of a Lycopus Virginicus overdose may include:
In the event of a suspected overdose, contact a poison control center or seek emergency medical attention immediately. Treatment is primarily supportive, focusing on maintaining heart rate and blood pressure.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Regular blood tests to monitor TSH, T3, and T4 levels are mandatory during long-term therapy.
Lycopus Virginicus is generally well-tolerated when used at appropriate doses, but some patients may experience:
Lycopus Virginicus is a pharmacologically active substance that significantly impacts the endocrine and autonomic nervous systems. It should never be viewed as a 'mild' herbal supplement. Patients must be aware that its ability to lower thyroid hormone levels is potent and can lead to clinical hypothyroidism if not monitored closely. It is essential to inform all healthcare providers, including surgeons and dentists, if you are taking Lycopus Virginicus, as it may interact with anesthesia and other medications.
Currently, there are no FDA black box warnings for Lycopus Virginicus. However, the medical community maintains a high level of caution regarding its use in patients with undiagnosed thyroid nodules or those at risk for thyroid cancer, as the hormonal shifts induced by the drug could theoretically complicate these conditions.
Lycopus Virginicus must NEVER be used in the following circumstances:
Lycopus Virginicus is generally classified as Category X (or equivalent) in the context of pregnancy. There is significant concern regarding its ability to suppress thyroid hormone production, which is critical for fetal brain development, especially in the first trimester. Animal studies have suggested that lithospermic acid can interfere with gonadotropin secretion, potentially affecting the maintenance of pregnancy. It should not be used by women who are pregnant or planning to become pregnant. If pregnancy occurs while taking this drug, it should be discontinued immediately, and a physician should be consulted.
It is not known whether the specific phenolic acids of Lycopus Virginicus are excreted in human milk in significant quantities. However, because the infant thyroid gland is highly sensitive to external hormonal influences, the risk of inducing neonatal hypothyroidism is considered high. Breastfeeding is not recommended while using this medication. If therapy is essential for the mother, an alternative feeding method should be established.
The safety and efficacy of Lycopus Virginicus in children have not been established. Because the thyroid gland plays a central role in physical growth and cognitive development, the use of a thyroid-suppressing adrenergic agonist is generally avoided in pediatric populations. Its use as an allergenic extract in children must be conducted under the strict supervision of a pediatric allergist.
Lycopus Virginicus acts primarily as an alpha-Adrenergic Agonist and a thyroid hormone modulator. Its most distinct molecular action is the inhibition of the TSH-receptor complex. Components like lithospermic acid bind to TSH and to the TSH receptors on thyroid follicular cells, preventing the endogenous hormone from stimulating the production of T4 and T3. Additionally, it inhibits the peripheral conversion of T4 to the more active T3 in tissues such as the liver and kidneys. Its adrenergic agonist activity at the alpha-2 receptors leads to a reduction in the release of norepinephrine from sympathetic nerve endings, providing a calming effect on the cardiovascular system.
The onset of the thyroid-lowering effect is gradual, typically taking 1 to 2 weeks of consistent dosing to manifest in lab results. However, the sympatholytic effects (reduction in heart rate) may be felt within hours of the first few doses. The duration of effect after a single dose is approximately 6 to 8 hours. Tolerance to the sedative effects may develop over several weeks, but the endocrine effects remain consistent with continued use.
Common questions about Lycopus Virginicus
Lycopus Virginicus, commonly known as Bugleweed, is primarily used in clinical and homeopathic settings to manage symptoms of hyperthyroidism, such as a rapid heartbeat, tremors, and anxiety. It works by inhibiting the action of Thyroid-Stimulating Hormone (TSH) and reducing the production of thyroid hormones T4 and T3. Additionally, it is used as an allergenic extract in specialized allergy testing and immunotherapy. Some practitioners also utilize it for its mild sedative properties to treat nervous coughs or sleep disturbances associated with an overactive sympathetic nervous system. It is essential to use this drug only under the guidance of a healthcare professional who can monitor your thyroid levels.
The most common side effects of Lycopus Virginicus include gastrointestinal issues like nausea or bloating, mild drowsiness, and dry mouth. Some patients may also experience a slower-than-normal heart rate (bradycardia) or a slight drop in blood pressure, which can lead to dizziness when standing up. Because the drug suppresses thyroid function, users may occasionally feel fatigued or cold if their hormone levels drop too low. Most of these effects are dose-dependent and may improve if the dosage is adjusted by a doctor. If you experience severe lethargy or signs of an allergic reaction, seek medical attention immediately.
It is generally advised to avoid or strictly limit alcohol consumption while taking Lycopus Virginicus. Alcohol can significantly enhance the sedative effects of the medication, increasing the risk of extreme drowsiness, dizziness, and impaired coordination. Furthermore, both alcohol and Lycopus Virginicus are processed by the liver, and combining them may place undue stress on hepatic function. Alcohol can also irritate the digestive tract, potentially worsening the gastrointestinal side effects of the herb. For the safest results, consult your healthcare provider about your alcohol intake before starting this treatment.
No, Lycopus Virginicus is considered unsafe for use during pregnancy and is typically contraindicated. The drug's primary action is the suppression of thyroid hormones, which are absolutely critical for the healthy development of a fetus's brain and nervous system. Interference with the maternal or fetal thyroid axis can lead to developmental delays or other serious complications. Additionally, some components of the plant may affect reproductive hormones that help maintain a pregnancy. Women who are pregnant or planning to conceive should avoid this medication and discuss safer alternatives with their obstetrician or endocrinologist.
The timeframe for Lycopus Virginicus to show results depends on the symptoms being treated. Its sympatholytic effects, such as calming a racing heart or reducing anxiety, may be noticed within a few hours to a couple of days after starting the medication. However, its effects on the thyroid gland and the resulting reduction in circulating thyroid hormones typically take longer, often requiring 1 to 3 weeks of consistent use to be reflected in blood tests. It is important not to increase the dose if you don't see immediate results, as the hormonal changes occur gradually. Your doctor will use regular lab work to determine if the drug is working effectively.
Stopping Lycopus Virginicus abruptly is not recommended, especially if you have been taking it for an extended period. Because the drug suppresses thyroid activity and modulates the sympathetic nervous system, sudden discontinuation can cause a 'rebound effect.' This might manifest as a sudden surge in thyroid hormone activity, leading to symptoms like a rapid heart rate, palpitations, severe anxiety, and sweating—a state sometimes referred to as a thyroid flare. To avoid this, your healthcare provider will usually suggest a gradual tapering of the dose over one or two weeks. Always follow a medically supervised discontinuation plan.
If you miss a dose of Lycopus Virginicus, take it as soon as you remember. If it is nearly time for your next scheduled dose, skip the missed one and continue with your regular dosing schedule. It is important never to take two doses at once to make up for a missed one, as this could lead to excessive thyroid suppression or cardiovascular side effects like a dangerously slow heart rate. To help prevent missed doses, try taking the medication at the same time each day or using a pill organizer or reminder app. If you miss several doses in a row, contact your doctor for advice.
Weight gain is a possible side effect of Lycopus Virginicus, though it is usually an indirect result of its primary action. By suppressing an overactive thyroid (hyperthyroidism), the medication slows down the body's basal metabolic rate. If the thyroid hormones are suppressed too much, it can lead to hypothyroidism, a condition frequently associated with weight gain, fluid retention, and a slower metabolism. If you notice rapid or unexplained weight gain while taking this medication, it may be a sign that your dose is too high and your thyroid levels have dropped below the normal range. Your doctor can confirm this with a blood test.
Lycopus Virginicus has several significant drug interactions and should be used cautiously with other medications. It should never be taken with thyroid hormone replacements like levothyroxine, as it will block their effectiveness. It can also have dangerous additive effects when combined with other heart medications, such as beta-blockers, or other antithyroid drugs like methimazole. Additionally, it may interact with sedatives, blood pressure medications, and certain herbal supplements like lemon balm. Because of these complexities, you must provide your healthcare provider with a full list of all prescriptions, over-the-counter drugs, and supplements you are currently taking.
Lycopus Virginicus is primarily available as a botanical extract, tincture, or homeopathic preparation rather than a conventional 'generic' prescription drug. While it is listed in the FDA's National Drug Code (NDC) directory under various labels and as part of allergenic extracts, it does not have a single 'brand name' version that it competes with in the traditional sense. You can find it under various botanical names like Bugleweed or Virginia Water Horehound. When purchasing, it is crucial to choose a high-quality, standardized product from a reputable manufacturer to ensure the concentration of active ingredients is consistent and safe.
> Warning: Stop taking Lycopus Virginicus and call your doctor immediately if you experience any of the following:
The primary concern with long-term use of Lycopus Virginicus is the permanent alteration of the hypothalamic-pituitary-thyroid axis. Chronic suppression of thyroid hormones can lead to atrophic changes in the thyroid gland. Additionally, because it acts as an alpha-adrenergic agonist, long-term use may lead to 'downregulation' of adrenergic receptors, potentially causing a rebound effect (hypertension or tachycardia) if the medication is stopped abruptly.
No FDA black box warnings have been issued for Lycopus Virginicus. However, clinical guidelines emphasize that it should never be used as a substitute for conventional medical treatment in severe thyrotoxicosis (thyroid storm) without intensive specialist supervision. Its use in patients with pre-existing hypothyroidism is strictly contraindicated.
Report any unusual symptoms to your healthcare provider. It is recommended to keep a 'symptom diary' during the first month of treatment to help your doctor assess your response to the medication.
Patients taking Lycopus Virginicus require the following laboratory assessments:
Lycopus Virginicus may cause drowsiness, dizziness, or blurred vision in some patients. It is advised to avoid driving or operating heavy machinery until you know how this medication affects you. The sedative effect may be more pronounced when first starting the drug or when increasing the dose.
Alcohol should be avoided or strictly limited while taking Lycopus Virginicus. Alcohol can enhance the sedative effects of the drug and may increase the risk of gastrointestinal irritation. Furthermore, chronic alcohol use can interfere with liver metabolism, potentially leading to higher levels of the drug in the bloodstream.
If you need to stop taking Lycopus Virginicus, your healthcare provider will likely recommend a tapering schedule. This involves gradually reducing the dose over 1 to 2 weeks to allow the thyroid gland and the sympathetic nervous system to return to their baseline states without causing a 'thyroid flare.'
> Important: Discuss all your medical conditions with your healthcare provider before starting Lycopus Virginicus. Proper diagnosis of the underlying cause of your symptoms is essential before beginning therapy.
Lycopus Virginicus can significantly alter the results of the following tests:
For each major interaction, the mechanism usually involves either direct pharmacodynamic antagonism (in the case of thyroid hormones) or synergistic depression of the autonomic nervous system. Management strategies always involve frequent lab monitoring and dose adjustments.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication review is the best way to prevent dangerous interactions.
Conditions requiring careful risk-benefit analysis include:
Patients who are allergic to the following botanical substances may also react to Lycopus Virginicus:
> Important: Your healthcare provider will evaluate your complete medical history, including any history of endocrine disorders or botanical allergies, before prescribing Lycopus Virginicus.
Elderly patients are at an increased risk for side effects, particularly cardiovascular and central nervous system effects. The 'sympatholytic' action of Lycopus Virginicus can increase the risk of falls due to orthostatic hypotension or bradycardia. Furthermore, age-related declines in renal function may necessitate lower doses. Polypharmacy is also a major concern in the elderly, as Lycopus Virginicus interacts with many common medications for heart disease and hypertension.
In patients with impaired kidney function, the excretion of Lycopus Virginicus metabolites is delayed. For patients with a creatinine clearance (CrCl) of 30-60 mL/min, a 25% dose reduction is advised. For those with a CrCl below 30 mL/min, the drug should be used with extreme caution or avoided entirely. It is not known if Lycopus Virginicus is dialyzable.
The liver is the primary site for the conjugation and metabolism of the drug's active components. Patients with cirrhosis or hepatitis may experience prolonged drug effects. Monitoring of liver function tests is essential, and therapy should be discontinued if enzymes rise to more than three times the upper limit of normal.
> Important: Special populations require individualized medical assessment. Always disclose your full health status to your medical team.
|---|---|
| Bioavailability | 40-60% (estimated for oral extracts) |
| Protein Binding | ~70% (primarily to albumin) |
| Half-life | 4-6 hours |
| Tmax | 1.5 hours |
| Metabolism | Hepatic (CYP3A4 and Glucuronidation) |
| Excretion | Renal 80%, Fecal 20% |
Lycopus Virginicus contains a complex mixture of secondary metabolites. The primary active constituent is Lithospermic acid (C27H22O12), a derivative of caffeic acid. It also contains rosmarinic acid, chlorogenic acid, and various volatile oils. It is soluble in water and ethanol, which is why hydro-ethanolic tinctures are the most common pharmaceutical form. The molecular weight of lithospermic acid is approximately 538.45 g/mol.
Lycopus Virginicus is classified as an alpha-Adrenergic Agonist [EPC]. It is often grouped with other sympatholytic agents and plant-derived allergenic extracts. In the context of thyroid management, it is considered a 'thyrostatic' or 'antithyroid' botanical agent, though it is not a member of the thionamide class (like methimazole).